E-LIB Suche - Ergebnisse für: Ganzel, Chezi

1

Gilteritinib with or without venetoclax for relapsed/refrac..:

Kugler, Eitan ; Cohen, Inbar ; Amitai, Irina...
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

2

Successful Treatment with Daratumumab of a Patient with Mon..:

Bnaya, Alon ; Ganzel, Chezi ; Shavit, Linda
Acta Haematologica. , 2024

Link: https://doi.org/10.1159/..

3

Venetoclax‐based salvage therapy for adult patients with re..:

Canaani, Jonathan ; Frisch, Avraham ; Pollyea, Daniel A....
European Journal of Haematology. 111 (2023) 3 - p. 365-372 , 2023

Link: https://doi.org/10.1111/..

4

Aspacytarabine for the treatment of patients with AML unfit..:

Altman, Jessica K. ; Zuckerman, Tsila ; Koprivnikar, Jamie...
Blood Advances. 7 (2023) 24 - p. 7494-7500 , 2023

Link: https://doi.org/10.1182/..

5

Pseudohyperkalemia in chronic lymphocytic leukemia: Prevale..:

Bnaya, Alon ; Ganzel, Chezi ; Shavit, Linda
The American Journal of the Medical Sciences. 366 (2023) 3 - p. 167-175 , 2023

Link: https://doi.org/10.1016/..

6

Process of drug registration in Israel: the correlation bet..:

Hiayev, Stephany ; Shacham-Shmueli, Einat ; Berkovitch, Matitiahu...
BMJ Open. 13 (2023) 5 - p. e067313 , 2023

Link: https://doi.org/10.1136/..

7

Real‐world experience with belantamab mafodotin therapy for..:

Shragai, Tamir ; Magen, Hila ; Lavi, Noa...
British Journal of Haematology. 200 (2022) 1 - p. 45-53 , 2022

Link: https://doi.org/10.1111/..

8

P-114: Real-world experience with belantamab mafodotin ther..:

Shragai, Tamir ; Magen, Hila ; Lavi, Noa...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S98 , 2022

Link: https://doi.org/10.1016/..

9

Anti-CD20 monoclonal antibodies inhibit seropositive respon..:

Tvito, Ariella ; Ronson, Aaron ; Ghosheh, Renan...
Experimental Hematology. 107 (2022) - p. 20-23 , 2022

Link: https://doi.org/10.1016/..

10

Measurable residual disease by flow cytometry in acute myel..:

Ganzel, Chezi ; Sun, Zhuoxin ; Baslan, Timour...
Leukemia Research. 123 (2022) - p. 106971 , 2022

Link: https://doi.org/10.1016/..

11

Gilteritinib monotherapy for relapsed/refractory FLT3 mutat..:

Shimony, Shai ; Canaani, Jonathan ; Kugler, Eitan...
Annals of Hematology. 101 (2022) 9 - p. 2001-2010 , 2022

Link: https://doi.org/10.1007/..

12

Correction to: Gilteritinib monotherapy for relapsed/refrac..:

Shimony, Shai ; Canaani, Jonathan ; Kugler, Eitan...
Annals of Hematology. 101 (2022) 9 - p. 2011-2011 , 2022

Link: https://doi.org/10.1007/..

13

Characteristics and outcome of multiple myeloma patients pr..:

Shragai, Tamir ; Gatt, Moshe E. ; Shaulov, Adir...
Leukemia Research. 101 (2021) - p. 106498 , 2021

Link: https://doi.org/10.1016/..

14

Identification of resistance pathways and therapeutic targe..:

Cohen, Yael C. ; Zada, Mor ; Wang, Shuang-Yin...
Nature Medicine. 27 (2021) 3 - p. 491-503 , 2021

Link: https://doi.org/10.1038/..

15

Venetoclax combinations induce high response rates in newly..:

Apel, Arie ; Moshe, Yakir ; Ofran, Yishai...
American Journal of Hematology. 96 (2021) 7 - p. 790-795 , 2021

Link: https://doi.org/10.1002/..